BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33202311)

  • 1. The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysis.
    Knisely A; Gamble CR; St Clair CM; Hou JY; Khoury-Collado F; Gockley AA; Wright JD; Melamed A
    J Minim Invasive Gynecol; 2021 Mar; 28(3):537-543. PubMed ID: 33202311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes.
    Fagotti A; Costantini B; Gallotta V; Cianci S; Ronsini C; Petrillo M; Pacciani M; Scambia G; Fanfani F
    J Minim Invasive Gynecol; 2015; 22(3):428-32. PubMed ID: 25461683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.
    Brown J; Drury L; Crane EK; Anderson WE; Tait DL; Higgins RV; Naumann RW
    J Minim Invasive Gynecol; 2019; 26(5):902-909. PubMed ID: 30240899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality Rates in Benign Laparoscopic and Robotic Gynecologic Surgery: A Systematic Review and Meta-analysis.
    Behbehani S; Suarez-Salvador E; Buras M; Magtibay P; Magrina J
    J Minim Invasive Gynecol; 2020; 27(3):603-612.e1. PubMed ID: 31627007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic management of advanced epithelial ovarian cancer after neoadjuvant chemotherapy: a phase II prospective multicenter non-randomized trial (the CILOVE study).
    Pomel C; Akladios C; Lambaudie E; Rouzier R; Ferron G; Lecuru F; Classe JM; Fourchotte V; Paillocher N; Wattiez A; Montoriol PF; Thivat E; Beguinot M; Canis M
    Int J Gynecol Cancer; 2021 Dec; 31(12):1572-1578. PubMed ID: 34670829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.
    Coleridge SL; Bryant A; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD005343. PubMed ID: 34328210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
    Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S
    Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally invasive interval cytoreductive surgery in ovarian cancer: systematic review and meta-analysis.
    Cardenas-Goicoechea J; Wang Y; McGorray S; Saleem MD; Carbajal Mamani SL; Pomputius AF; Markham MJ; Castagno JC
    J Robot Surg; 2019 Feb; 13(1):23-33. PubMed ID: 29992404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of robotic surgery in gynecology: robotic techniques compared with laparoscopy and laparotomy.
    Gala RB; Margulies R; Steinberg A; Murphy M; Lukban J; Jeppson P; Aschkenazi S; Olivera C; South M; Lowenstein L; Schaffer J; Balk EM; Sung V;
    J Minim Invasive Gynecol; 2014; 21(3):353-61. PubMed ID: 24295923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer.
    Morton M; Chambers LM; Costales AB; Chichura A; Gruner M; Horowitz MP; Rose PG; Yao M; Debernardo R; Michener C
    Gynecol Oncol; 2021 Jan; 160(1):45-50. PubMed ID: 33067001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer.
    Conte C; Marchetti C; Loverro M; Giudice MT; Rosati A; Gallotta V; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2023 Feb; 33(2):137-144. PubMed ID: 36639195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE).
    Nitecki R; Rauh-Hain JA; Melamed A; Scambia G; Pareja R; Coleman RL; Ramirez PT; Fagotti A
    Int J Gynecol Cancer; 2020 Sep; 30(9):1450-1454. PubMed ID: 32690591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes.
    Eriksson AGZ; Graul A; Yu MC; Halko A; Chi DS; Zivanovic O; Gardner GJ; Sonoda Y; Barakat RR; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2017 Aug; 146(2):263-267. PubMed ID: 28527673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysis.
    Bogani G; Borghi C; Leone Roberti Maggiore U; Ditto A; Signorelli M; Martinelli F; Chiappa V; Lopez C; Sabatucci I; Scaffa C; Indini A; Ferrero S; Lorusso D; Raspagliesi F
    J Minim Invasive Gynecol; 2017; 24(4):552-562. PubMed ID: 28223182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive surgical staging for early stage ovarian cancer: A long-term follow up.
    Gallotta V; Jeong SY; Conte C; Trozzi R; Cappuccio S; Moroni R; Ferrandina G; Scambia G; Kim TJ; Fagotti A
    Eur J Surg Oncol; 2021 Jul; 47(7):1698-1704. PubMed ID: 33573854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Surgical Strategies in the Treatment of Gynecological Malignancies.
    Angeles MA; Martínez-Gómez C; Migliorelli F; Voglimacci M; Figurelli J; Motton S; Tanguy Le Gac Y; Ferron G; Martinez A
    Curr Treat Options Oncol; 2018 Nov; 19(12):73. PubMed ID: 30411170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysis.
    Nitecki R; Ramirez PT; Frumovitz M; Krause KJ; Tergas AI; Wright JD; Rauh-Hain JA; Melamed A
    JAMA Oncol; 2020 Jul; 6(7):1019-1027. PubMed ID: 32525511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy.
    Davidson BA; Broadwater G; Crim A; Boccacio R; Bixel K; Backes F; Previs RA; Salinaro J; Salani R; Moore K; Secord AA
    Gynecol Oncol; 2019 Mar; 152(3):554-559. PubMed ID: 30558972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
    Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
    Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single institution's experience with minimally invasive surgery for ovarian cancer, and a systematic meta-analysis of the literature.
    Kamei Y; Kobayashi E; Nakatani E; Shiomi M; Sawada M; Kakuda M; Toda A; Nakagawa S; Hiramatsu K; Kinose Y; Takiuchi T; Miyoshi A; Kodama M; Hashimoto K; Kimura T; Ueda Y; Sawada K; Kimura T
    Int J Clin Oncol; 2023 Jun; 28(6):794-803. PubMed ID: 37115425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.